Navigation Links
A 'bionic nose' that knows
Date:3/30/2009

Both cancer cells and the chemicals used to make bombs can foil detection because they appear in trace amounts too small for conventional detection techniques. Tel Aviv University has developed the ultimate solution: a molecule that can magnify weak traces of "hidden" molecules into something we can detect and see.

Using molecular techniques in nanotechnology, Prof. Doron Shabat of TAU's Raymond and Beverly Sackler School of Chemistry has engineered new molecules that have the power to identify targets -- such as biomarkers in cancer, materials in explosives, or pollutants in water --even when present in miniscule amounts. Prof. Shabat's invention, like a bionic nose, can "sniff out" these trace molecules and amplify them tenfold, making them noticeable for doctors and crimefighters.

Details of Prof. Shabat's project appeared in a paper published in the journal Chemical Communication last year.

Fights Chemical and Biological Threats In Our Bodies and Environment

Prof. Shabat, a bioorganic chemist, plans to develop the technology so that it amplifies signals millions and billions times stronger than they are. "We are developing a molecular system that amplifies certain events," says Prof. Shabat. "That way we'll be able to respond faster to medical, security and environmental threats. In effect, our device can amplify just about any chemical system that has a certain kind of reactivity."

"It has the potential to help doctors diagnose diseases -- those with biomarkers, and enzymatic activities that are compatible with our molecular probe," says Prof. Shabat. "The long list includes a few kinds of cancer, as well, including prostate cancer. But it also has applications for testing for impurities in water. It has both biological and non-biological applications."

A Track-and-Trace Solution

Prof. Shabat's invention is a molecular sensor that acts in a solution. A chemist would add trace amounts of the test material from the field -- a spoonful of contaminated drinking water, for example -- into the solution and would simply see if the color of the solution changes. If so, the targeted material -- the cancer, or explosive, or pollutant -- is present.

As of now, Prof. Shabat's is a unique solution. The prototype is ready, and Prof. Shabat plans to use it to "amplify" problems around the world to improve healthcare, safety, and security. Some of the research behind the new invention was done in collaboration with the Scripps Research Institute in San Diego.


'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert

Related medicine news :

1. Bioniche Responds to Australian Equine Influenza Outbreak
2. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
3. Bioniche Food Safety Vaccine Receives Global Top Honours in Industry Excellence Awards
4. Bioniche Receives Comment from USDA on a Field Trial for E. coli O157:H7 Cattle Vaccine
5. Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
6. Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference
7. Bioniche Reports Fiscal 2008 First Quarter
8. Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario
9. Bioniche Amends Terms of Convertible Debt with Laurus Master Funds
10. USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine
11. Bioniche Reports Fiscal 2008 Second Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... in Wethersfield, Conn., has relocated its corporate headquarters to a new, more expansive ... , In October 2016, Qualidigm purchased a distressed office building in Wethersfield, ...
(Date:3/28/2017)... ... March 28, 2017 , ... METTLER ... ions found in power plant water and steam. , Chlorides and sulfates cause ... boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at low ...
(Date:3/28/2017)... ... ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio and ... to sit on the 2017 National Advisory Board for Allergan’s Facial Aesthetics National Advisory ... propel the clinic from a small start-up to number 78 in the country based ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon Balloon System ... procedure adds to SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. ...
(Date:3/28/2017)... ... ... With expansion and efficiency in mind, Patten Seed Company completed relocation of its ... in Marshallville in 2006, and a bagging and shipping facility has been in place ... Seed operations to the Middle Georgia location from their previous home in Lakeland, Georgia. ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017 Therapix Biosciences ... company specializing in the development of cannabinoid-based drugs, today ... the United States of ... 40 ordinary shares of the Company, at a ... has granted the underwriters a 45-day over-allotment option ...
(Date:3/27/2017)... Germany , March 27, 2017 ... over 7,000 attendees and more than 600 exhibitors ... and discover opportunities and solutions that will advance ... 6 April 2017 at the Messe Stuttgart, ... the preeminent medical technology platform showcasing the key ...
(Date:3/27/2017)... NEW YORK , March 27, 2017 ... ... that adult use in states where cannabis is legal will generate ... $559 million will be from cannabis specific taxes, such as ... remaining $96 million will be earned from state sales taxes that ...
Breaking Medicine Technology: